BNP Paribas Financial Markets’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-150
| Closed | -$767 | – | 3629 |
|
|
2022
Q1 | $767 | Buy |
150
+1
| +0.7% | +$5 | ﹤0.01% | 3412 |
|
|
2021
Q4 | $839 | Hold |
149
| – | – | ﹤0.01% | 3417 |
|
|
2021
Q3 | $1.65K | Sell |
149
-30
| -17% | -$332 | ﹤0.01% | 3221 |
|
|
2021
Q2 | $3.04K | Sell |
179
-470
| -72% | -$7.97K | ﹤0.01% | 3237 |
|
|
2021
Q1 | $17K | Sell |
649
-513
| -44% | -$13.5K | ﹤0.01% | 3214 |
|
|
2020
Q4 | $42K | Sell |
1,162
-48
| -4% | -$1.74K | ﹤0.01% | 2979 |
|
|
2020
Q3 | $42.8K | Buy |
1,210
+1,083
| +853% | +$38.3K | ﹤0.01% | 2924 |
|
|
2020
Q2 | $5.4K | Sell |
127
-163
| -56% | -$6.93K | ﹤0.01% | 3347 |
|
|
2020
Q1 | $23.2K | Buy |
290
+155
| +115% | +$12.4K | ﹤0.01% | 3252 |
|
|
2019
Q4 | $12.5K | Buy |
135
+89
| +193% | +$8.21K | ﹤0.01% | 3432 |
|
|
2019
Q3 | $3.47K | Buy |
46
+41
| +820% | +$3.1K | ﹤0.01% | 3666 |
|
|
2019
Q2 | $458 | Buy |
+5
| New | +$458 | ﹤0.01% | 3786 |
|